Entrepreneur Universe Bright Group (EUBG)
OTCMKTS · Delayed Price · Currency is USD
0.3149
+0.0049 (1.58%)
Aug 1, 2025, 9:34 AM EDT
Revance Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.